Matt Mailman

Biography

 Matt Mailman, Ph.D. is the R&D IT Business Technology Leader accountable for coordinating digital health, advanced analytics and experimental execution technology to enable the Janssen Diagnostics strategy. Before joining R&D IT, Matt served as Director and Solution Development Team Leader in the Janssen Neuroscience therapeutic area. During his six years in Janssen R&D, he developed companion and complementary diagnostics as well as digital solutions aimed at differentiating and advancing the Alzheimer’s disease and schizophrenia portfolio. Prior to joining Janssen, Matt was Manager of Tailored Therapeutics IT and Senior Biomedical Informatics Scientist at Eli Lilly where he built informatics platforms that support the formulation of pharmacogenomic precision medicine hypotheses. Before that, he led the development of the widely utilized Database of Genotype and Phenotype (dbGaP) at the National Center for Biotechnology Information (NIH). Matt received his Ph.D. in molecular pathology from the Ohio State University, M.S in oncology from the University of Wisconsin at Madison and M.S. in bioinformatics during his postdoctoral fellowship at the University of Pennsylvania, Philadelphia, Pennsylvania.

Research Interest

 Molecular pathology, oncology